AzTrials
AzTrials

Ambulatory Laparoscopic HysterectomyRANDOLILNCT04165148

Low Impact Laparoscopy Concept Versus Conventional Laparoscopy

A study testing Low Impact Laparoscopy, conventional laparoscopy and Visual Analog Scale (VAS) for Pain in people with Ambulatory Laparoscopic Hysterectomy, run by Hospices Civils de Lyon at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Outpatient surgical management has been developing in recent years and High Authority of Health recommendations in French for this type of management is a postoperative pain score of less than 3 on the VAS. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Ambulatory Laparoscopic Hysterectomy
What is being tested?
Low Impact Laparoscopy, conventional laparoscopy and Visual Analog Scale (VAS) for Pain
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteFrance
Study dates
3 Jun 2020to 3 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • women over 18 years
  • planned surgery procedure : ambulatory laparoscopic hysterectomy
  • effective contraception if women of childbearing age
  • patients with free, informed and signed consent

Who cannot join

  • disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....)
  • pregnancy or wish for subsequent pregnancy
  • lactating women
  • contraindication to laparoscopy
  • contraindication to minimally invasive endoscopic techniques
  • not eligible for outpatient care
  • inability to understand the information given
  • a person not affiliated to a social security scheme, or deprived of liberty, or under guardianship.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Femme Mère Enfant

    Bron, 69677

Other trials in France

About this study

Official title: Randomized Study Comparing the Low Impact Laparoscopy Concept to Conventional Laparoscopy in Terms of Ambulatory Care

Outpatient surgical management has been developing in recent years and High Authority of Health recommendations in French for this type of management is a postoperative pain score of less than 3 on the VAS.

The feasibility and safety of laparoscopy is well established, particularly in the field of gynecology, but this technique often causes postoperative pain. Techniques are being developed to reduce postoperative pain in laparoscopic surgery. Low pressure insufflation (7 to 10 mmHg) compared to standard pressure insufflation (12 to 15 mmHg) significantly reduces postoperative pain. Microcoelioscopy (use of 3 mm trocars instead of 5 to 12 mm trocars in standard laparoscopy), by reducing the size of incisions, also significantly reduces postoperative pain.

Read more

The Low Impact Laparoscopy is a minimally invasive technique that combines low pressure insufflation and microcoelioscopy which would have the advantage of reducing postoperative pain. This technique would therefore, by reducing postoperative pain, to improve outpatient management, particularly in cases of hysterectomies for which the outpatient management rate could be increased.

The hypothesis is that using the Low Impact Laparoscopy concept would increase outpatient management rate compared to conventional laparoscopy in gynecological surgeries for hysterectomy.

The study aims to compare the Low Impact Laparoscopy concept with conventional laparoscopy in terms of ambulatory care rates in patients undergoing surgery for hysterectomy.

Being tested
Low Impact Laparoscopy, conventional laparoscopy, Visual Analog Scale (VAS) for Pain, Saint-Antoine Pain Questionnaire (QDSA), post-operative questionnaire
Keywords
Low Impact Laparoscopy, laparoscopy, hysterectomy, ambulatory

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low Impact LaparoscopyDevice

    Low Impact Laparoscopy is a minimally invasive technique that combines low pressure insufflation (with the iFS AirSeal® system) and microcoelioscopy (with specific microtrocards and laparoscopic instruments).

  • conventional laparoscopyDevice

    conventional laparoscopy

  • Visual Analog Scale (VAS) for PainOther

    The patient evaluates her pain using an VAS scale on arrival in the post-interventional surveillance room, then 30 minutes, 2 hours, 4 hours, 6 hours after leaving the operating roo, at the exit of post-interventional surveillance room and at the exit of the hospital.

    The day after surgery, according to the usual practice, outpatients receive a telephone call from a Gynecologist. The assessment of their pain (with VAS scale) will be collected.

    During the usual consultation at 1 month, the patient must evaluate her pain by means of an VAS.

  • Saint-Antoine Pain Questionnaire (QDSA)Other

    The patient evaluates her pain using an QDSA questionnaire on arrival in the post-interventional surveillance room, then 30 minutes, 2 hours, 4 hours, 6 hours after leaving the operating roo, at the exit of post-interventional surveillance room and at the exit of the hospital.

    The day after surgery, according to the usual practice, outpatients receive a telephone call from a Gynecologist. The assessment of their pain (with QDSA questionnaire) will be collected.

    During the usual consultation at 1 month, the patient must evaluate her pain by means of an QDSA questionnaire.

  • post-operative questionnaireOther

    The patient will fill in the antalgic intake record and the patient booklet for the collection of medical consumptions from her discharge from the hospital and during the month following the surgery.

Study groups in NCT04165148
Study groupRoleWhat they receive
Low Impact LaparoscopyExperimentalLow Impact Laparoscopy is a minimally invasive technique that combines low pressure insufflation (with the Intelligent Flow System (iFS) AirSeal® system) and microcoelioscopy (with specific microtrocards and laparoscopic instruments).
Receives: Device: Low Impact Laparoscopy; Other: Visual Analog Scale (VAS) for Pain; Other: Saint-Antoine Pain Questionnaire (QDSA); Other: post-operative questionnaire
conventional laparoscopyActive comparatorconventional laparoscopy
Receives: Device: conventional laparoscopy; Other: Visual Analog Scale (VAS) for Pain; Other: Saint-Antoine Pain Questionnaire (QDSA); Other: post-operative questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. success rate of ambulatory care

    rate of patients actually managed on an outpatient setting (discharged from hospital the same day of the intervention) and who presented no complication or rehospitalization in the month following the intervention

    Measured: 1 month after surgery

Secondary outcomes (27)
  1. pain score (Visual analogic scale (VAS) for pain)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: arrival in the post-interventional surveillance room

  2. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: 30 minutes after exit of operating room

  3. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: 2 hours after exit of operating room

  4. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: 4 hours after exit of operating room

  5. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: 6 hours after exit of operating room

  6. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: at the exit of a post-interventional surveillance room, an average of 2 hours after arrival

  7. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: on leaving the hospital, an average of 8 hours after surgery

  8. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: the day after surgery

  9. pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Measured: 1 month after surgery

  10. pain score (Saint-Antoine Pain Questionnaire (QDSA questionnaire))

    Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64.

    Measured: 6 hours after exit of operating room

  11. pain score (Saint-Antoine Pain Questionnaire (QDSA))

    Pain score assessed by QDSA short questionnaire (Saint-Antoine Pain Questionnaire) : list of 16 qualifiers to describe pain, score ranging from 0 to 64

    Measured: the day after surgery

  12. dose of morphine

    total dose of morphine (miligramme (mg)) administered in the post-interventional surveillance room

    Measured: at the exit of a post-interventional surveillance room, an average of 2 hours after arrival

  13. number of patients who needed an analgesic

    number of patients who needed an analgesic supplement in post-interventional monitoring room

    Measured: at the exit of a post-interventional surveillance room, an average of 2 hours after arrival

  14. number of patients who needed an analgesic

    number of patients who needed an analgesic supplement in post-interventional monitoring room

    Measured: on leaving the hospital, an average of 8 hours after surgery

  15. number of patients who needed an analgesic

    number of patients who needed an analgesic supplement in post-interventional monitoring room

    Measured: 1 month after surgery

  16. total administered dose

    total administered dose of analgesic supplement (mg) in post-interventional monitoring room

    Measured: at the exit of a post-interventional surveillance room, an average of 2 hours after arrival

  17. total administered dose

    total administered dose of analgesic supplement (mg) in post-interventional monitoring room

    Measured: on leaving the hospital, an average of 8 hours after surgery

  18. total administered dose

    total administered dose of analgesic supplement (mg) in post-interventional monitoring room

    Measured: 1 month after surgery

  19. duration of analgesic treatment

    duration of analgesic treatment (days) during the hospital stay

    Measured: on leaving the hospital

  20. duration of analgesic treatment

    duration of analgesic treatment (days) during the hospital stay

    Measured: 1 month after surgery

  21. operating time

    operative time (between incision and closure) in minutes

    Measured: at the exit of the operating room, an average of 30 minutes after surgery

  22. number of per and postoperative complications

    number of per and postoperative complications

    Measured: 1 month after surgery

  23. types of per and postoperative complications

    description of per and postoperative complications

    Measured: 1 month after surgery

  24. hours total of stay in the post-intervention monitoring room

    length of stay in the post-interventional surveillance room in hours

    Measured: at the exit of a post-interventional surveillance room

  25. number of days of hospital stay

    length of hospital stay (if non ambulatory care) in number of days

    Measured: on leaving the hospital

  26. number of days of work stoppage

    duration of work stoppage of the patient in number of days

    Measured: 1 month after surgery

  27. patient management costs

    Patient management costs according to the two surgical strategies

    Measured: 1 month after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2019
  2. Study start3 Jun 2020
  3. Primary completion3 Jan 2023
  4. Study completion3 Sep 2023

Why it stopped: There is no more material

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04165148
Sponsor's protocol ID
69HCL19_0335
Other IDs
2019-A01863-54
Acronym
RANDOLIL
Status last verified
Apr 2024
First submitted
7 Nov 2019
Last updated
18 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Low Impact Laparoscopy, conventional laparoscopy and Visual Analog Scale (VAS) for Pain in people with Ambulatory Laparoscopic Hysterectomy, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: There is no more material). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

success rate of ambulatory care (time frame: 1 month after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in